Welcome to LookChem.com Sign In|Join Free

CAS

  • or

119757-57-2

Post Buying Request

119757-57-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (E/Z)-1-[4-(2-Chloroethoxy)phenyl]-1-(4-hydroxyphenyl)-2-phenyl-1-butene

    Cas No: 119757-57-2

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier

119757-57-2 Usage

Chemical Properties

Brown Foam

Uses

An intermediate in the syntheis of a metabolite of the anti-cancer drug Tamoxifen

Check Digit Verification of cas no

The CAS Registry Mumber 119757-57-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,7,5 and 7 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 119757-57:
(8*1)+(7*1)+(6*9)+(5*7)+(4*5)+(3*7)+(2*5)+(1*7)=162
162 % 10 = 2
So 119757-57-2 is a valid CAS Registry Number.
InChI:InChI=1/C24H23ClO2/c1-2-23(18-6-4-3-5-7-18)24(19-8-12-21(26)13-9-19)20-10-14-22(15-11-20)27-17-16-25/h3-15,26H,2,16-17H2,1H3/b24-23+

119757-57-2Relevant articles and documents

High affinity fluorescent ligands for the estrogen receptor

Abendroth, Frank,Solleder, Marthe,Mangoldt, Dorothea,Welker, Pia,Licha, Kai,Weber, Marcus,Seitz, Oliver

, p. 2157 - 2166 (2015/04/14)

Fluorescent binders of the estrogen receptor (ER) are used in binding assays and in detection or imaging studies. However, fluorescence labelling of ER ligands usually leads to substantial decreases in binding affinity. In this study, we describe the deve

Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator

Shoda, Takuji,Okuhira, Keiichiro,Kato, Masashi,Demizu, Yosuke,Inoue, Hideshi,Naito, Mikihiko,Kurihara, Masaaki

, p. 87 - 89 (2014/01/17)

We designed and synthesized an estrogen receptor (ER) down-regulator (5), which is a derivative of tamoxifen with a long alkyl side chain. Compound 5 effectively reduced ER protein levels in MCF-7 cells and had an antagonistic effect.

ENDOXIFEN METHODS AND COMPOSITIONS

-

Page/Page column 32, (2008/12/06)

The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of breast cancer and other breast

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119757-57-2